Typhoid Toxin and Salmonella Typhi pathogenesis

伤寒毒素和伤寒沙门氏菌发病机制

基本信息

  • 批准号:
    9121477
  • 负责人:
  • 金额:
    $ 50.54万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-09-16 至 2019-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Salmonella enterica serovar Typhi (S. Typhi) and the related serovar S. Paratyphi cause typhoid fever in humans, a devastating disease that results in ~500,000 deaths every year. Although most of the cases occur in developing countries, outbreaks occasionally occur in the United States. Unlike other Salmonella enterica serovars, which can infect a variety of hosts and can cause limited gastroenteritis (e. g. food poisoning), S. Typhi and S. Paratyphi are exclusive human pathogen and causes systemic, often lethal, disease. Despite being one of the earliest recognized pathogens in human history, the pathogenesis of S. Typhi still remains poorly understood. The molecular bases for S. Typhi's remarkable host specificity are also poorly understood. Genome sequence data suggest that a combination of genome degradation and acquisition of unique genetic information may account for S. Typhi's unique biology. One of the very few virulence factors that are unique to typhoidal serovars of S. enterica is Typhoid toxin, which was recently discovered in our laboratory. Typhoid toxin is an atypical AB toxin in that it has two enzymatically active subunits: an ADP ribosyl transferase (PltA) and a deoxyribonuclease (CdtB), which are homologs of the active subunits of pertussis and cytolethal distending toxins, respectively. These two subunits are covalently linked to one another and are associated to a homopentameric B subunit composed of PltB. We have recently discovered that systemic administration of purified typhoid toxin can recapitulate many of the symptoms of typhoid fever in mice. This is a very exciting discovery since it not only links typhoid toxin to the pathogenesis of typhoid fever but also provides concrete bases for the development of novel prevention as well as potentially life-saving therapeutic strategies. Typhoid toxin exhibits a remarkable biology in that it is only produced by intracellularly located bacteria, and after its synthesis and assembly, it is released into the Salmonella-containing vacuole. From this location, the toxin is then packaged into vesicle carriers and exported to the extracellular medium, from where it finds its way into target cells by interacting with specific surface receptors. Our laboratory has recently identified the surface receptors for typhoid toxin, which revealed unique insights into the biology of this toxin. In addition, we have discovered that a Rab32 and BLOC-3-dependent pathogen surveillance mechanism restricts the growth of S. Typhi in mice. We intend to leverage these exciting findings to carry out a series of research objectives that, through the study of typhoid toxin, we hope will deepen our understanding of typhoid fever and the pathogenesis of S. Typhi infection.
描述(由申请人提供):肠道沙门氏菌血清鼠伤寒(S. typhi)和相关的血清链球菌在人类中引起伤寒,这是一种毁灭性的疾病,每年造成约500,000人死亡。尽管大多数案件发生在发展中国家,但爆发偶尔发生在美国。与其他可以感染各种宿主并可能导致胃肠炎有限(例如食物中毒)的肠道肠道血清射手不同,typhi链球菌和副链球菌是人类病原体的独家病原体,并引起全身性,通常是致命的,疾病。尽管是人类历史上最早公认的病原体之一,但鼠伤寒沙门氏菌的发病机理仍然知之甚少。 S. typhi显着的宿主特异性的分子碱基也很少了解。基因组序列数据表明,基因组降解和对独特遗传信息的获取的结合可能解释了S. typhi的独特生物学。肠形肠链球菌伤寒的毒力因子极少数是伤寒毒素,最近在我们的实验室中发现了伤寒毒素。伤寒毒素是一种非典型的AB毒素,它具有两个酶活性亚基:ADP核糖基转移酶(PLTA)和一个脱氧核糖核酸酶(CDTB),它们是百日咳和细胞降低差异毒素的活性亚基的同源物。这两个亚基相互共价链接,并与由PLTB组成的同型B亚基相关联。我们最近发现,纯化伤寒毒素的全身给药可以概括小鼠伤寒的许多症状。这是一个非常令人兴奋的发现,因为它不仅将伤寒毒素与伤寒发烧的发病机理联系起来,而且还为开发新型预防以及潜在的挽救生命的治疗策略提供了具体基础。伤寒毒素表现出显着的生物学,因为它仅由细胞内细菌产生,在其合成和组装后,它被释放到含沙门氏菌的液泡中。然后从这个位置将毒素包装到囊泡载体中,并导出到细胞外培养基中,从那里从那里找到了它的方式 与特定的表面受体相互作用。我们的实验室最近确定了伤寒毒素的表面受体,该受体揭示了对这种毒素的生物学的独特见解。此外,我们发现RAB32和BLOC-3依赖性病原体监测机制限制了小鼠孢子链球菌的生长。我们打算利用这些令人兴奋的发现来实现一系列研究目标,通过研究伤寒毒素,我们希望我们将加深对伤寒和伤寒链球菌感染的发病机理的理解。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Jorge E Galan其他文献

Jorge E Galan的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Jorge E Galan', 18)}}的其他基金

Campylobacter jejuni restriction by the intestinal microbiota
空肠弯曲菌受肠道微生物群的限制
  • 批准号:
    10734573
  • 财政年份:
    2023
  • 资助金额:
    $ 50.54万
  • 项目类别:
Diet transformation by the microbiome and its impact on bacterial infection
微生物组的饮食转变及其对细菌感染的影响
  • 批准号:
    10512774
  • 财政年份:
    2022
  • 资助金额:
    $ 50.54万
  • 项目类别:
Diet transformation by the microbiome and its impact on bacterial infection
微生物组的饮食转变及其对细菌感染的影响
  • 批准号:
    10684849
  • 财政年份:
    2022
  • 资助金额:
    $ 50.54万
  • 项目类别:
Campylobacter jejuni colonization and the resident microbiota
空肠弯曲菌定植和常驻微生物群
  • 批准号:
    8994717
  • 财政年份:
    2015
  • 资助金额:
    $ 50.54万
  • 项目类别:
Typhoid Toxin and Salmonella Typhi pathogenesis
伤寒毒素和伤寒沙门氏菌发病机制
  • 批准号:
    10231229
  • 财政年份:
    2014
  • 资助金额:
    $ 50.54万
  • 项目类别:
Typhoid Toxin and Salmonella Typhi pathogenesis
伤寒毒素和伤寒沙门氏菌发病机制
  • 批准号:
    10461034
  • 财政年份:
    2014
  • 资助金额:
    $ 50.54万
  • 项目类别:
Typhoid Toxin and Salmonella Typhi pathogenesis
伤寒毒素和伤寒沙门氏菌发病机制
  • 批准号:
    9330055
  • 财政年份:
    2014
  • 资助金额:
    $ 50.54万
  • 项目类别:
Typhoid Toxin and Salmonella Typhi pathogenesis
伤寒毒素和伤寒沙门氏菌发病机制
  • 批准号:
    10686399
  • 财政年份:
    2014
  • 资助金额:
    $ 50.54万
  • 项目类别:
Typhoid Toxin and Salmonella Typhi pathogenesis
伤寒毒素和伤寒沙门氏菌发病机制
  • 批准号:
    10023150
  • 财政年份:
    2014
  • 资助金额:
    $ 50.54万
  • 项目类别:
Typhoid Toxin and Salmonella Typhi pathogenesis
伤寒毒素和伤寒沙门氏菌发病机制
  • 批准号:
    8799676
  • 财政年份:
    2014
  • 资助金额:
    $ 50.54万
  • 项目类别:

相似国自然基金

髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
  • 批准号:
    82372496
  • 批准年份:
    2023
  • 资助金额:
    48 万元
  • 项目类别:
    面上项目
利用碱基编辑器治疗肥厚型心肌病的动物模型研究
  • 批准号:
    82300396
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目
利用小型猪模型评价动脉粥样硬化易感基因的作用
  • 批准号:
    32370568
  • 批准年份:
    2023
  • 资助金额:
    50.00 万元
  • 项目类别:
    面上项目
丁苯酞通过调节细胞异常自噬和凋亡来延缓脊髓性肌萎缩症动物模型脊髓运动神经元的丢失
  • 批准号:
    82360332
  • 批准年份:
    2023
  • 资助金额:
    31.00 万元
  • 项目类别:
    地区科学基金项目
APOBEC3A驱动膀胱癌发生发展的动物模型及其机制研究
  • 批准号:
    82303057
  • 批准年份:
    2023
  • 资助金额:
    30.00 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Antibody-based therapy for fentanyl-related opioid use disorder
基于抗体的芬太尼相关阿片类药物使用障碍治疗
  • 批准号:
    10831206
  • 财政年份:
    2023
  • 资助金额:
    $ 50.54万
  • 项目类别:
RR&D Research Career Scientist Award Application
RR
  • 批准号:
    10754152
  • 财政年份:
    2023
  • 资助金额:
    $ 50.54万
  • 项目类别:
Mentoring the next generation of substance use, HIV, and epigenetic researchers in sexual and gender minority health
指导下一代性和性别少数健康领域的药物滥用、艾滋病毒和表观遗传学研究人员
  • 批准号:
    10699933
  • 财政年份:
    2023
  • 资助金额:
    $ 50.54万
  • 项目类别:
Rat and Canine Microphysiological Systems of the Kidney Proximal Tubule for Chemical Toxicity Screening
用于化学毒性筛查的大鼠和犬肾近端小管微生理系统
  • 批准号:
    10363049
  • 财政年份:
    2021
  • 资助金额:
    $ 50.54万
  • 项目类别:
Hyaluronan as a mediator of intrauterine growth restriction-induced islet dysfunction in type 2 diabetes
透明质酸作为 2 型糖尿病宫内生长受限诱导的胰岛功能障碍的介质
  • 批准号:
    10303293
  • 财政年份:
    2021
  • 资助金额:
    $ 50.54万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了